[PRESSWIRE] CA, US - 18 September, 2020 -- Airionex announced today the results of new independent testing. Varionix® active bipolar ionization air cleaning technology from Airionex has been verified to be effective for disinfecting coronavirus from the air. The virus was completely eliminated within minutes.

Anthemis and IA Capital Group Participate in Round; Nephila Capital and Munich Re to Provide Risk Capacity...

[PRESSWIRE] Vienna - 30th June 2020 -- Eveliqure Biotechnologies today announces that further financing has been secured from Arax Capital Partners comprising the last instalment of a €1.7M total investment provided by Arax. This is complemented by further private investment from Baobá and a Swiss based family office, and totals around €0.5M.

[PRESSWIRE] Vienna - 4 June, 2020 -- The Austrian biotech company CEBINA GmbH announces that it has received seed funding for its extended spectrum Coronavirus vaccine project, which is part of CEBINA’s broad-scale efforts offering short-, mid- and longer-term solutions to fight the COVID-19 pandemic. This seed funding will support proof-of-concept studies of the vaccine that will allow progress to pre-clinical development, scheduled for Q1/2021. The funds are provided by the Blom Family Office.

[PRESSWIRE] Brussels - 2 June, 2020 -- The EBRAINS shared Research Infrastructure for brain research is pleased to announce a significant step forward with the appointment of its founding CEO Paweł Świeboda. The EBRAINS digital brain research infrastructure is a key outcome of the European Commission’s Flagship 10-year research initiative Human Brain Project.

[PRESSWIRE] Vienna - 2nd June 2020 -- Eveliqure Biotechnologies today, announces that the Hungarian regulatory agency OGYÈI has approved the clinical trial for its vaccine program to prevent diarrhoeal diseases caused by Shigella and Enterotoxigenic E. coli (ETEC).  

[PRESSWIRE] Austria - 20 April, 2020 -- Austrian biotech company Calyxha Biotechnologies GmbH is pleased to announce the grant of European Patent No. EP3383381. This patent covers the use of calixarene compounds for neurodegenerative diseases, including Parkinson’s disease. It represents the company’s first granted patent, with prosecution of the corresponding patent applications ongoing in other territories.

[PRESSWIRE] HELSINKI – 16 April, 2020 -- Karsa Oy, developer and manufacturer of chemical threat detectors for security applications, has launched a new business enterprise, Karsa Oy (Deutschland),  in the Republic of Germany. Its innovative Chemical Ionization Mass Spectrometry technology was originally developed for climate change research and has been initially adapted for the detection of explosives in air cargo.  

[PRESSWIRE] Charlotte, NORTH CAROLINA - 30 March, 2020 -- Over the past two weeks, the leading magazine for autism families rapidly responded to the changing needs of the autism community by providing sought after autism COVID-19 resources. Autism Parenting Magazine Editor-in-Chief Amy KD Tobik said coming together to develop tools such as social stories and visual schedules, along with professional advice, was critical.

[PRESSWIRE] Chicago, IL United States - 19 March, 2020 -- Surgisphere has developed a COVID-19 triage tool that helps prioritize care for patients who are in urgent need of care.